CynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. It develops assays that can measure the oligomeric and aggregated forms of ß-amyloid, α-synuclein, and phospho-tau in blood.